Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- 1253 Copenhagen K
- Most recent report
- 6-K, filed Oct 13, 2026
- Filings on record
- 563 filings
- On EDGAR
- CIK 1434265
- Filer status
- Large accelerated filer
Financials 8 of 490
- 6-K Report a foreign issuer made public elsewhere Oct 13, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 7, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 5, 2026
- 6-K Report a foreign issuer made public elsewhere Oct 2, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 29, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 24, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 9, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 9, 2026
Prospectuses and Registrations 8 of 11
- S-8 Registration statement for an employee plan Feb 17, 2026
- S-8 Registration statement for an employee plan Feb 12, 2025
- S-8 Registration statement for an employee plan Feb 22, 2024
- S-8 Registration statement for an employee plan Feb 24, 2022
- S-8 Registration statement for an employee plan Feb 25, 2021
- 424B4 Final prospectus for an offering Jul 19, 2019
- S-8 Registration statement for an employee plan Jul 17, 2019
- FWP Free writing prospectus Jul 16, 2019
Ownership 8 of 22
- SCHEDULE 13G Large holder reported a passive stake Oct 5, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 17, 2026
- 4 Insider reported a trade Dec 30, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended Dec 30, 2025
- 4 Insider reported a trade Dec 29, 2025
- 4 Insider reported a trade Dec 22, 2025
Other 8 of 40
Everything here comes from Genmab A/s's own filings on SEC EDGAR. The filing list is rechecked every hour.